CCO Infectious Disease Podcast

410 Episodes

1. PrEP Considerations for Transgender and Nonbinary Individuals

   Published: 1/5/2023
2. Optimizing PrEP Selection and Persistence for MSM

   Published: 1/5/2023
3. What Strategies Are Most Promising for Prevention and Treatment of Long COVID in Nonhospitalized Patients?

   Published: 1/4/2023
4. Should We Be Concerned About Resistance and Development of New Variants With COVID-19 Antiviral Therapy?

   Published: 1/4/2023
5. ART Selection in Treatment-Naive PWH: Weight Gain Considerations

   Published: 12/30/2022
6. Should We Be Concerned About Viral Rebound With Antiviral Agents?

   Published: 12/30/2022
7. Selecting First-line ART in Treatment-Naive Persons With HIV

   Published: 12/29/2022
8. If Treatment Supply Is Limited in Future COVID-19 Viral Peaks, How Do We Ethically Prioritize Patients for Treatment?

   Published: 12/29/2022
9. Promoting Meningococcal Vaccine Equity in Adolescent Patients

   Published: 12/29/2022
10. Will New COVID-19 Vaccines Affect Risk Stratification?

    Published: 12/27/2022
11. The Future of Long-Acting HIV Care: What’s Still Needed

    Published: 12/22/2022
12. Improving Access and Acceptance of HIV PrEP for People Who Inject Drugs

    Published: 12/20/2022
13. Answering the Questions on Monkeypox in PWH

    Published: 12/19/2022
14. Answering the Questions on Considering an ART Switch During Pregnancy

    Published: 12/19/2022
15. Expanding Access to Long-Acting ART in Europe

    Published: 12/19/2022
16. Whom to Screen for Hepatitis Delta Virus

    Published: 12/15/2022
17. Hong Kong Perspective: Should Older Age Influence Hepatitis B Treatment Decisions?

    Published: 12/15/2022
18. What Patients Want in HIV Treatment and Prevention: Africa

    Published: 12/14/2022
19. What Patients Want in HIV Treatment and Prevention: Malaysia

    Published: 12/7/2022
20. Addressing ART Safety and Tolerability in Transgender Individuals

    Published: 12/7/2022